Showing results (1601-1610 of 1,753) with videos related to

Sort By:
Pageof 176
Nature Communications|February 22, 2025
The role of Tyr34 in proton coupled electron transfer and product inhibition of manganese superoxide dismutaseJahaun Azadmanesh, Katelyn Slobodnik, Lucas R Struble, et al.
Surgery|November 18, 2022
Engineering functional 3-dimensional patient-derived endocrine organoids for broad multiplatform applicationsNaira Baregamian, Konjeti R Sekhar, Evan S Krystofiak, et al.
Atherosclerosis|February 29, 2024
Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglyceridesJing Li, Liping Yang, Jun Song, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|April 29, 2016
Comparison of Pediatric Severe Sepsis Managed in U.S. and European ICUsJohn S Giuliano, Barry P Markovitz, Joe Brierley, et al.
Shock (Augusta, Ga.)|July 26, 2023
SERUM SOLUBLE ENDOGLIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE ORGAN DYSFUNCTION SYNDROMEMihir R Atreya, Natalie Z Cvijanovich, Julie C Fitzgerald, et al.
Oncoimmunology|May 15, 2023
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)A Daban, C Gonnin, L Phan, et al.
The Journal of Pediatrics|October 17, 2015
Identifying Pediatric Severe Sepsis and Septic Shock: Accuracy of Diagnosis CodesFran Balamuth, Scott L Weiss, Matt Hall, et al.
World Journal of Urology|March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomyAndrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.
Revue D'Epidemiologie Et De Sante Publique|December 14, 2017
Hospitalization of HIV positive patients: Significant demand affecting all hospital sectorsR Seng, P Mutuon, J Riou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell supportR J Morgan, J H Doroshow, K Venkataraman, et al.
Pageof 176